HEG1 and non-small cell lung carcinoma: Churg and Naso have recently hypothesized that the use of only two immunostains usually could enable the highly accurate differentiation between epithelioid/biphasic mesotheliomas from NSCLC carcinomas using HEG1 and Claudin-4 IHC labelling in combination (12).